You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 24, 2024

Claims for Patent: 6,455,569

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,455,569

Title:	Connective tissue softening
Abstract:	The use of Matrix Metalloproteinase Inhibitors in the prevention or treatment of connective tissue softening and also for the maintenance of sutures in such connective tissues. The connective tissue may be a tendon, ligament or cartilage.
Inventor(s):	Ferguson; Mark W. J. (Derbyshire, GB)
Assignee:	Renovo LTD (Manchester, DE)
Application Number:	09/913,713
Patent Claims:	1. A method of preventing or treating a softening of connective tissue selected from the group consisting of a tendon, ligament or cartilage due to injury comprising administering to a subject in need of such treatment a therapeutically effective amount of a matrix metalloproteinase inhibitor. 2. The method according to claim 1, wherein the inhibitor is a collagenase inhibitor. 3. The method according to claim 1, wherein the inhibitor is a Tissue Inhibitor of Metalloproteinases (TIMP). 4. The method according to claim 1, wherein the inhibitor is an inhibitor of MMP1 or MMP8. 5. The method according to claim 1, wherein the inhibitor is BB-94. 6. The method according to claim 1, wherein the inhibitor is GM6001. 7. The method according to claim 1, wherein the inhibitor is a synthetic organic molecule based on hydroxamic acid. 8. The method according to claim 1, wherein the matrix metalloproteinase inhibitor is administered by topical application. 9. The method according to claim 1, wherein the matrix metalloproteinase inhibitor is administered by an injection. 10. The method according to claim 1, wherein the matrix metalloproteinase inhibitor is administered by a slow release device. 11. The method according to claim 1, wherein the matrix metalloproteinase inhibitor is administered in the first 14 days following injury.

Details for Patent 6,455,569

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965	⤷ Try a Trial	2019-02-18
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.